GlassScriptPhysician profile
Frank Kalaba
NPI 1750744157
$7,997.36
in general payments reported to CMS, 2019-2025
21 companies · $653 in 2025
The $653 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $343 · 2021: $353 · 2022: $601 · 2023: $1,349 · 2024: $4,698 · 2025: $653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,699.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $2,212.88 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $860.11 | 2021-2024 | Repatha |
| Boston Scientific Corporation | $811.99 | 2020-2024 | Avvigo Guidance System, Mach1, Ffr Link Bluetooth Communication Module |
| Terumo Medical Corporation | $736.87 | 2024-2025 | Metacross Otw, Glidewire, Angio-Seal |
| Biotronik INC. | $683.14 | 2023-2025 | Orsiro Mission, Pantera Leo, Nhancer Rx |
| Medtronic, INC. | $678.03 | 2021-2024 | Hawkone, Symplicity G3, Corevalve Evolut R |
| Bard Peripheral Vascular, INC. | $447.85 | 2024 | Lutonix Drug Coated Balloon, Crosser Iq, Ultraverse 014 |
| Chiesi USA, INC. | $403.98 | 2024-2025 | Kengreal, Cleviprex |
| Pfizer INC. | $222.62 | 2022-2024 | |
| Edwards Lifesciences Corporation | $169.35 | 2021-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Genzyme Corporation | $149.99 | 2022 | |
| Medtronic Vascular, INC. | $132.96 | 2020 | |
| Novo Nordisk INC | $114.82 | 2022 | |
| Cardiovascular Systems INC. | $106.72 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $73.18 | 2024-2025 | Andexxa, Wainua |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $60.53 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Imperative Care, INC | $37.96 | 2025 | Prodigy Catheter |
| Cardiva Medical, INC. | $26.94 | 2023 | Cardiva Vascade 5f Vcs |
| Limflow INC. | $26.89 | 2023 | Limflow System |
| Baxter Healthcare | $26.05 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Atricure, INC. | $14.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Kalaba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.